WESTPORT, Conn., July 21 /PRNewswire/ -- IMS HEALTH (NYSE: RX) today
announced the appointment of J. Michal Conaway as chief financial officer,
with responsibility for the company's global financial strategy, planning and
reporting activities. He will report to Victoria R. Fash, IMS HEALTH's
president and chief operating officer, and will be based in London.
"As CFO for a $14-billion-dollar multinational company, Michal gained
extensive experience in global finance and strategic planning that will be
invaluable as IMS HEALTH pursues its growth strategy," said Ms. Fash. "His
international focus and expertise in mergers and acquisitions will provide
strong support as we build our worldwide operations."
Conaway, 49, directed the financial function at Fluor Corporation for the
past five years, most recently as senior vice president & chief financial
officer. During his tenure at Fluor, Conaway played an integral role in the
acquisition and integration of several international companies.
From 1988 to 1992, Conaway was vice president & chief financial officer
and a director of National Gypsum Company, where he led a significant and
successful financial restructuring of the company.
For the previous 14 years, Conaway held progressively responsible
management positions with Texas Eastern Corporation. He joined the company in
1974, rising to become senior vice president and chief financial officer from
1985 to 1987.
Conaway completed the Program for Management Development at Harvard
University's Graduate School of Business, holds an MBA degree from Pepperdine
University, and received a B. S. degree in accounting from Abilene Christian
University. He is a Certified Public Accountant.
IMS HEALTH is the world's leading provider of information solutions to the
pharmaceutical and healthcare industries. With more than $1 billion in 1997
revenue, IMS HEALTH operates in over 90 countries. IMS HEALTH is the largest
pharmaceutical manufacturer information partner, with over 40 years'
experience in the industry. Key products and services integral to customer
day-to-day operations include: market research for prescription and
over-the-counter pharmaceutical products; sales management information to
optimize sales force productivity; technology enabled selling solutions for
sales and marketing decision-making; and technology systems and information
services that support managed care organizations.
Additional information is available at http://www.imshealth.com.
SOURCE IMS HEALTH
 back to top
Related links:
http://www.imshealth.com
CONTACT:
Michael Gury of IMS HEALTH, 203-222-4230
|
